when is tirzepatide approved Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea Tirzepatide (Mounjaro) – Advanced Care

3032 GLP-1-RAs were first created for type-2 diabetes but are now licensed for obesity management

This gives providers the clinical flexibility to increase, hold, or reduce dose based on your actual week-to-week response

In the SURMOUNT-5 head-to-head trial against semaglutide, tirzepatide at maximum dose produced 20.2% weight loss compared to semaglutide at 13.7%

Eating smaller, more frequent meals instead of large portions reduces the burden on a slowed digestive system

Key Takeaways Starting dose: 2.5 mg once weekly for 4 weeks (sub-therapeutic, intended for tolerability) Titration pace: Increase every 4 weeks: 2.5 5 7.5 10 12.5 15 mg Maintenance options: 5, 10, or 15 mg

As the body regulates blood sugar more efficiently and burns fat for energy, patients often feel more active and motivated to incorporate physical activities into their daily routine